Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Diagnostic Pathology|February 5, 2023
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumorsKristýna Němejcová, Michaela Kendall Bártů, Romana Michálková, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 5, 2023
Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 CasesMichaela Kendall Bártů, Kristýna Němejcová, Romana Michálková, et al.
Virchows Archiv : an International Journal of Pathology|May 13, 2022
The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significancePavel Dundr, Barbora Bazalová, Michaela Bártů, et al.
Pathology|July 27, 2023
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significancePavel Dundr, Nikola Hájková, Michaela Kendall Bártů, et al.
Breast (Edinburgh, Scotland)|November 6, 2025
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34Stephanie Kacerovsky-Strobl, Christine Deutschmann, Dominik Hlauschek, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 27, 2023
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genesNikola Hájková, Michaela Kendall Bártů, David Cibula, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic CategoriesPavel Dundr, Michaela Bártů, Tjalling Bosse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial CarcinomasAmy Jamieson, Lisa Vermij, Claire J H Kramer, et al.
Molecular Cancer|May 29, 2023
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancerSandra Kendzia, Susanne Franke, Tarek Kröhler, et al.
Virchows Archiv : an International Journal of Pathology|February 19, 2021
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinomaNicole Concin, Carien L Creutzberg, Ignace Vergote, et al.
Pageof 6